AbCellera
first partnered program in covid resulted in treatments for patients together with our partner developed two antibody treatments authorized by the us to treat covid aes eerie | AbCellera
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
13 of 19
Related slides by other companies
Absci
Investor Presentation
October 2023
we are leveraging our platform advantages to create internal programs | Absci
Aeglea BioTherapeutics
Investor Presentation
August 2020
program cystinuria | Aeglea BioTherapeutics
MindMed
Investor Presentation
June 2023
business highlights our mission is to deliver on the therapeutic potential of and other novel targets to treat brain health disorders a leader in developing product candidates to treat brain health i diversified pipeline of clinical programs targeting significant unmet medical needs and strategies intended to maximize market exclusivity and protection leveraging decades of research on clinical and preclinical potential of product candidates in drug and digital medicine development and commercialization expected cash runway through key clinical and into first half of | MindMed
Compass Therapeutics
Investor Presentation
May 2022
company overview | Compass Therapeutics
Other recent decks by AbCellera
See all presentations (23 decks)
Investor Presentation
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io